María Eugenia De la Morena Barrio

Palma-Barqueros V, Bury L, Kunishima S, Lozano ML, Rodriguez-Alen A, Revilla N, Bohdan N, Padilla J, Fernandez-Perez MP, de la Morena-Barrio ME, Marin-Quilez A, Benito R, Lopez-Fernandez MF, Marcellini S, Zamora-Canovas A, Vicente V, Martinez C, Gresele P, Bastida JM, Rivera J. Expanding the genetic spectrum of TUBB1-related thrombocytopenia. Blood Adv. 2021 Dec 28;5(24):5453-5467. doi: 10.1182/bloodadvances.2020004057. Erratum In: Blood Adv. 2023 Mar 28;7(6):877. PubMed PMID: 34516618; PubMed Central PMCID: PMC8714720.

AÑO: 2021; IF: 7.637

34516618

Bravo-Perez C, Serna MJ, Esteban J, Fernandez-Mellid E, Fontanes-Trabazo E, Lorenzo A, Calvino-Suarez M, Minano A, Padilla J, Roldan V, Vicente V, Corral J, de la Morena-Barrio ME. Anticoagulant therapy in patients with congenital FXI deficiency. Blood Adv. 2021 Oct 26;5(20):4083-4086. doi: 10.1182/bloodadvances.2021005695. PubMed PMID: 34597376; PubMed Central PMCID: PMC8945614.

AÑO: 2021; IF: 7.637

34597376

de la Morena-Barrio ME, Gindele R, Bravo-Perez C, Ilonczai P, Zuazu I, Speker M, Olah Z, Rodriguez-Sevilla JJ, Entrena L, Infante MS, de la Morena-Barrio B, Garcia JM, Schlammadinger A, Cifuentes-Riquelme R, Mora-Casado A, Minano A, Padilla J, Vicente V, Corral J, Bereczky Z. High penetrance of inferior vena cava system atresia in severe thrombophilia caused by homozygous antithrombin Budapest 3 variant: Description of a new syndrome. Am J Hematol. 2021 Nov 1;96(11):1363-1373. doi: 10.1002/ajh.26304. Epub 2021 Aug 12. PubMed PMID: 34324211.

AÑO: 2021; IF: 13.265

34324211

Orlando C, de la Morena-Barrio B, Pareyn I, Vanhoorelbeke K, Martinez-Martinez I, Vicente V, Corral J, Jochmans K, de la Morena-Barrio ME. Antithrombin p.Thr147Ala: The First Founder Mutation in People of African Origin Responsible for Inherited Antithrombin Deficiency. Thromb Haemost. 2021 Feb;121(2):182-191. doi: 10.1055/s-0040-1716531. Epub 2020 Sep 13. PubMed PMID: 32920809.

AÑO: 2021; IF: 6.681

32920809

Fernandez-Perez MP, Aguila S, Reguilon-Gallego L, de Los Reyes-Garcia AM, Minano A, Bravo-Perez C, de la Morena ME, Corral J, Garcia-Barbera N, Gomez-Verdu JM, Bernal E, Herranz MT, Vicente V, Martinez C, Gonzalez-Conejero R, Lozano ML. Neutrophil extracellular traps and von Willebrand factor are allies that negatively influence COVID-19 outcomes. Clin Transl Med. 2021 Jan;11(1):e268. doi: 10.1002/ctm2.268. No abstract available. PubMed PMID: 33463053; PubMed Central PMCID: PMC7775985.

AÑO: 2021; IF: 8.554

33463053